Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.07
0.041.97%
At close: Aug 19, 5:00 PM EST
$2.09
0.02161.04%
After Hours: 6:52 PM EST
Gain Therapeutics Inc (GANX) Stock Price, Quote, News & History
GANXNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Gain Therapeutics (GANX) stock?
You can purchase shares of Gain Therapeutics (NASDAQ:GANX) through any online brokerage.
Who are Gain Therapeutics (GANX) competitors?
Other companies in Gain Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
What is the forecast, or price target, for Gain Therapeutics (GANX) stock?
Gain Therapeutics has a consensus price target of $7.56.
What is the current price for Gain Therapeutics (GANX)?
The stock price for Gain Therapeutics (NASDAQ: GANX) is $2.0916 last updated August 19, 2026 at 6:52 PM EDT.
Does Gain Therapeutics (GANX) pay a dividend?
There are no upcoming dividends for Gain Therapeutics.
When is Gain Therapeutics (NASDAQ:GANX) reporting earnings?
Gain Therapeutics does not have any upcoming earnings scheduled.
Is Gain Therapeutics (GANX) going to split?
There is no upcoming split for Gain Therapeutics.
What sector and industry does Gain Therapeutics (GANX) operate in?
Gain Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
